Post by colormist on Nov 14, 2008 8:55:15 GMT -5
FDA Safety Changes
www.medscape.com/viewarticle/583397
Excerpt:
One small step for the FDA, one giant leap for HFI.
I'm just glad they're finally acknowledging our issues on labels. Now if we could just get out name to that list of warning ingredients (milk, soy, wheat allergy labels).
www.medscape.com/viewarticle/583397
Excerpt:
Extended-Release Methylphenidate HCl (Metadate CD) Contraindicated in Certain Settings
On August 26, the FDA approved class safety labeling revisions for methylphenidate HCl extended-release capsules (Metadate CD; UCB, Inc) to warn against its use in certain settings.
Because methylphenidate extended-release capsules contain sucrose, they should not be used in patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency.
One small step for the FDA, one giant leap for HFI.
I'm just glad they're finally acknowledging our issues on labels. Now if we could just get out name to that list of warning ingredients (milk, soy, wheat allergy labels).